Home LiteratureArticle Details
PMID: 18596921 Published · ppublish English Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

The Journal of clinical investigation ·Vol. 118 ·No. 8 ·2008-08-00 ·Pages 2822-31

Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N

Abstract

Idiopathic hypogonadotropic hypogonadism (IHH) with anosmia (Kallmann syndrome; KS) or with a normal sense of smell (normosmic IHH; nIHH) are heterogeneous genetic disorders associated with deficiency of gonadotropin-releasing hormone (GnRH). While loss-of-function mutations in FGF receptor 1 (FGFR1) cause human GnRH deficiency, to date no specific ligand for FGFR1 has been identified in GnRH neuron ontogeny. Using a candidate gene approach, we identified 6 missense mutations in FGF8 in IHH probands with variable olfactory phenotypes. These patients exhibited varied degrees of GnRH deficiency, including the rare adult-onset form of hypogonadotropic hypogonadism. Four mutations affected all 4 FGF8 splice isoforms (FGF8a, FGF8b, FGF8e, and FGF8f), while 2 mutations affected FGF8e and FGF8f isoforms only. The mutant FGF8b and FGF8f ligands exhibited decreased biological activity in vitro. Furthermore, mice homozygous for a hypomorphic Fgf8 allele lacked GnRH neurons in the hypothalamus, while heterozygous mice showed substantial decreases in the number of GnRH neurons and hypothalamic GnRH peptide concentration. In conclusion, we identified FGF8 as a gene implicated in GnRH deficiency in both humans and mice and demonstrated an exquisite sensitivity of GnRH neuron development to reductions in FGF8 signaling.

MeSH Terms
Adult Animals Case-Control Studies Cohort Studies Female Fibroblast Growth Factor 8/chemistry,genetics,metabolism Gonadotropin-Releasing Hormone/deficiency,genetics,metabolism Heterozygote Humans Hypogonadism/genetics,physiopathology Kallmann Syndrome/genetics,physiopathology Male Mice Mice, Transgenic Models, Molecular Mutation Neurons/cytology,metabolism Olfaction Disorders/genetics Pedigree Signal Transduction
Chemicals
FGF8 protein, human Fgf8 protein, mouse Fibroblast Growth Factor 8 Gonadotropin-Releasing Hormone
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Falardeau John
Harvard Center for Reproductive Endocrine Sciences and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital (MGH), Boston, Massachusetts 02114, USA.
Chung Wilson C J
Beenken Andrew
Raivio Taneli
Plummer Lacey
Sidis Yisrael
Jacobson-Dickman Elka E
Eliseenkova Anna V
Ma Jinghong
Dwyer Andrew
Quinton Richard
Na Sandra
Hall Janet E
Huot Celine
Alois Natalie
Pearce Simon H S
Cole Lindsay W
Hughes Virginia
Mohammadi Moosa
Tsai Pei
Pitteloud Nelly
References (53)
53 references, click to expand
  1. Dosage of Fgf8 determines whether cell survival is positively or negatively regulated in the developing forebrain.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1757-62 PMID: 12574514
  2. Structure and sequence of human FGF8.
    Genomics. 1996 Jul 1;35(1):253-7 PMID: 8661131
  3. Soluble factors guide gonadotropin-releasing hormone axonal targeting to the median eminence.
    Endocrinology. 2000 Sep;141(9):3065-71 PMID: 10965875
  4. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination.
    Nat Genet. 1998 Feb;18(2):136-41 PMID: 9462741
  5. Testosterone and estrogen act via different pathways to inhibit puberty in the male Siberian hamster (Phodopus sungorus).
    Endocrinology. 2001 Aug;142(8):3309-16 PMID: 11459772
  6. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
    Genes Dev. 2006 Jan 15;20(2):185-98 PMID: 16384934
  7. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.
    Endocr Rev. 1998 Oct;19(5):521-39 PMID: 9793755
  8. Live view of gonadotropin-releasing hormone containing neuron migration.
    Endocrinology. 2005 Jan;146(1):463-8 PMID: 15486219
  9. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant.
    J Clin Endocrinol Metab. 2005 May;90(5):3122-7 PMID: 15728198
  10. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
    J Biol Chem. 2006 Jun 9;281(23):15694-700 PMID: 16597617
  11. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.
    N Engl J Med. 1997 Nov 27;337(22):1597-602 PMID: 9371856
  12. Reversal of idiopathic hypogonadotropic hypogonadism.
    N Engl J Med. 2007 Aug 30;357(9):863-73 PMID: 17761590
  13. The GPR54 gene as a regulator of puberty.
    N Engl J Med. 2003 Oct 23;349(17):1614-27 PMID: 14573733
  14. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.
    Genes Dev. 1999 Jul 15;13(14):1834-46 PMID: 10421635
  15. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Mol Cell Endocrinol. 2006 Jul 25;254-255:60-9 PMID: 16764984
  16. Impaired FGF signaling contributes to cleft lip and palate.
    Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4512-7 PMID: 17360555
  17. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.
    Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8928-32 PMID: 1409588
  18. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci.
    Science. 1994 Jun 10;264(5165):1604-8 PMID: 8202715
  19. Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population.
    Mol Endocrinol. 2005 Jan;19(1):225-36 PMID: 15459253
  20. Genetics of Hirschsprung disease.
    Curr Opin Pediatr. 2000 Dec;12(6):610-7 PMID: 11106284
  21. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.
    Hum Mutat. 1998;11(1):1-3 PMID: 9450896
  22. Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse.
    Development. 2005 Dec;132(23):5211-23 PMID: 16267092
  23. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
    J Clin Invest. 2007 Feb;117(2):457-63 PMID: 17235395
  24. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    J Clin Endocrinol Metab. 2001 Apr;86(4):1532-8 PMID: 11297579
  25. Signalling by FGF8 from the isthmus patterns anterior hindbrain and establishes the anterior limit of Hox gene expression.
    Development. 2000 Jan;127(1):177-86 PMID: 10654611
  26. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Ann Intern Med. 1986 Jun;104(6):777-82 PMID: 3706929
  27. Structural basis for fibroblast growth factor receptor activation.
    Cytokine Growth Factor Rev. 2005 Apr;16(2):107-37 PMID: 15863029
  28. The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum.
    Development. 2003 Jun;130(12):2633-44 PMID: 12736208
  29. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome.
    Front Neuroendocrinol. 2004 Jul;25(2):108-30 PMID: 15571757
  30. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    PLoS Genet. 2006 Oct 20;2(10):e175 PMID: 17054399
  31. Role of the isthmus and FGFs in resolving the paradox of neural crest plasticity and prepatterning.
    Science. 2002 Feb 15;295(5558):1288-91 PMID: 11847340
  32. FGF signaling through FGFR1 is required for olfactory bulb morphogenesis.
    Development. 2003 Mar;130(6):1101-11 PMID: 12571102
  33. Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands.
    J Biol Chem. 1997 Feb 7;272(6):3733-8 PMID: 9013630
  34. Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning.
    Nature. 2008 May 15;453(7193):401-5 PMID: 18449196
  35. Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility.
    N Engl J Med. 1997 Feb 6;336(6):410-5 PMID: 9010147
  36. Genomic structure, sequence, and mapping of human FGF8 with no evidence for its role in craniosynostosis/limb defect syndromes.
    Am J Med Genet. 1997 Oct 31;72(3):354-62 PMID: 9332670
  37. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17447-52 PMID: 17959774
  38. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8.
    Endocrinology. 2006 May;147(5):2171-82 PMID: 16439448
  39. Influence of hypophysectomy, sham hypophysectomy and other surgical procedures on luteal function in the rhesus monkey.
    Endocrinology. 1968 Feb;82(2):410-5 PMID: 4951286
  40. Spatiotemporal cell expression of luteinizing hormone-releasing hormone in the prenatal mouse: evidence for an embryonic origin in the olfactory placode.
    Brain Res Dev Brain Res. 1989 Apr 1;46(2):309-18 PMID: 2655994
  41. Developmental regulation of gonadotropin-releasing hormone neurons by fibroblast growth factor signaling.
    Endocrinology. 2004 Aug;145(8):3830-9 PMID: 15117872
  42. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo.
    Development. 1995 Feb;121(2):439-51 PMID: 7768185
  43. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
    Nat Genet. 2003 Apr;33(4):463-5 PMID: 12627230
  44. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.
    J Clin Endocrinol Metab. 2002 Jan;87(1):152-60 PMID: 11788640
  45. Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies.
    J Clin Endocrinol Metab. 1999 Mar;84(3):1028-36 PMID: 10084591
  46. Neocortex patterning by the secreted signaling molecule FGF8.
    Science. 2001 Nov 2;294(5544):1071-4 PMID: 11567107
  47. Sex differences in odor identification ability: a cross-cultural analysis.
    Neuropsychologia. 1985;23(5):667-72 PMID: 4058710
  48. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.
    N Engl J Med. 1982 Nov 11;307(20):1237-41 PMID: 6813732
  49. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.
    J Clin Endocrinol Metab. 2005 Mar;90(3):1317-22 PMID: 15613419
  50. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6281-6 PMID: 16606836
  51. Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants.
    Development. 2003 May;130(9):1903-14 PMID: 12642494
  52. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone.
    Endocr Rev. 1986 Feb;7(1):11-23 PMID: 3082615
  53. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
    Mol Cell. 2000 Sep;6(3):743-50 PMID: 11030354
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2008-08-00
Pages
2822-31
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC2441855
Subset
IM
Grants
NICHD NIH HHS · R01 HD042708 · United States
NICHD NIH HHS · R01 HD015788 · United States
NICHD NIH HHS · U54HD028138-16 · United States
NICHD NIH HHS · R01 HD015788-21 · United States
NIDCR NIH HHS · R01 DE13686-08 · United States
NCRR NIH HHS · M01 RR001066 · United States
NICHD NIH HHS · R01 HD42708 · United States
NIDCR NIH HHS · R01 DE013686 · United States
NICHD NIH HHS · U54 HD028138 · United States
NCRR NIH HHS · M01-RR-01066 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com